BDSX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Biodesix Inc (BDSX).


$222.56M Market Cap.

As of 03/03/2025 5:00 PM ET (MRY) • Disclaimer

BDSX Market Cap. (MRY)


BDSX Shares Outstanding (MRY)


BDSX Assets (MRY)


Total Assets

$97.24M

Total Liabilities

$76.37M

Total Investments

$0

BDSX Income (MRY)


Revenue

$71.32M

Net Income

-$42.93M

Operating Expense

$90.25M

BDSX Cash Flow (MRY)


CF Operations

-$48.65M

CF Investing

-$3.44M

CF Financing

$52.05M

BDSX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

BDSX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$97,244,000 (-1.87%)

$99,096,000 (6.66%)

$92,906,000 (22.09%)

$76,097,000 (-37.15%)

Assets Current

$39,484,000 (-0.50%)

$39,683,000 (-25.60%)

$53,334,000 (22.29%)

$43,613,000 (-49.37%)

Assets Non-Current

$57,760,000 (-2.78%)

$59,413,000 (50.14%)

$39,572,000 (21.82%)

$32,484,000 (-7.00%)

Goodwill & Intangible Assets

$20,905,000 (-8.88%)

$22,942,000 (-7.60%)

$24,828,000 (-6.83%)

$26,648,000 (-5.81%)

Shareholders Equity

$20,876,000 (355.81%)

$4,580,000 (-77.77%)

$20,606,000 (4.46%)

$19,727,000 (-52.08%)

Property Plant & Equipment Net

$29,595,000 (-0.06%)

$29,612,000 (235.70%)

$8,821,000 (111.08%)

$4,179,000 (31.50%)

Cash & Equivalents

$26,245,000 (-0.15%)

$26,284,000 (-39.00%)

$43,088,000 (31.72%)

$32,712,000 (-47.35%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$678,000 (109.26%)

$324,000 (-66.32%)

$962,000 (-48.00%)

$1,850,000 (-47.62%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$8,603,000 (12.03%)

$7,679,000 (51.61%)

$5,065,000 (38.54%)

$3,656,000 (-76.11%)

Trade & Non-Trade Payables

$2,194,000 (-25.09%)

$2,929,000 (73.83%)

$1,685,000 (1.38%)

$1,662,000 (-81.46%)

Accumulated Retained Earnings (Deficit)

-$462,497,000 (-10.23%)

-$419,566,000 (-14.19%)

-$367,420,000 (-21.67%)

-$301,973,000 (-16.68%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$61,976,000 (2.12%)

$60,691,000 (90.55%)

$31,850,000 (218.12%)

$10,012,000 (-63.94%)

Debt Current

$740,000 (144.22%)

$303,000 (-80.97%)

$1,592,000 (8278.95%)

$19,000 (-99.84%)

Debt Non-Current

$61,236,000 (1.40%)

$60,388,000 (99.58%)

$30,258,000 (202.79%)

$9,993,000 (-37.25%)

Total Liabilities

$76,368,000 (-19.20%)

$94,516,000 (30.73%)

$72,300,000 (28.26%)

$56,370,000 (-29.45%)

Liabilities Current

$14,317,000 (-57.16%)

$33,416,000 (46.31%)

$22,839,000 (-21.14%)

$28,960,000 (-9.85%)

Liabilities Non-Current

$62,051,000 (1.56%)

$61,100,000 (23.53%)

$49,461,000 (80.45%)

$27,410,000 (-42.63%)

BDSX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$71,323,000 (45.30%)

$49,087,000 (28.46%)

$38,212,000 (-29.89%)

$54,506,000 (19.64%)

Cost of Revenue

$15,573,000 (19.70%)

$13,010,000 (-8.08%)

$14,154,000 (-53.62%)

$30,518,000 (38.73%)

Selling General & Administrative Expense

$80,451,000 (19.39%)

$67,387,000 (9.64%)

$61,462,000 (21.67%)

$50,517,000 (44.93%)

Research & Development Expense

$9,559,000 (-4.30%)

$9,988,000 (-23.77%)

$13,102,000 (2.45%)

$12,789,000 (18.22%)

Operating Expenses

$90,248,000 (16.57%)

$77,419,000 (3.72%)

$74,645,000 (17.91%)

$63,306,000 (38.60%)

Interest Expense

$8,258,000 (-13.40%)

$9,536,000 (18.14%)

$8,072,000 (79.06%)

$4,508,000 (-40.72%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$42,931,000 (17.67%)

-$52,146,000 (20.32%)

-$65,447,000 (-51.64%)

-$43,159,000 (-37.67%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$42,931,000 (17.67%)

-$52,146,000 (20.32%)

-$65,447,000 (-51.64%)

-$43,159,000 (-37.67%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$42,931,000 (17.67%)

-$52,146,000 (20.32%)

-$65,447,000 (-51.64%)

-$43,159,000 (-37.67%)

Weighted Average Shares

$129,670,000 (57.92%)

$82,113,000 (95.03%)

$42,103,000 (53.86%)

$27,365,000 (465.63%)

Weighted Average Shares Diluted

$129,670,000 (57.92%)

$82,113,000 (95.03%)

$42,103,000 (53.86%)

$27,365,000 (465.63%)

Earning Before Interest & Taxes (EBIT)

-$34,673,000 (18.63%)

-$42,610,000 (25.73%)

-$57,375,000 (-48.44%)

-$38,651,000 (-62.77%)

Gross Profit

$55,750,000 (54.53%)

$36,077,000 (49.96%)

$24,058,000 (0.29%)

$23,988,000 (1.82%)

Operating Income

-$34,498,000 (16.55%)

-$41,342,000 (18.28%)

-$50,587,000 (-28.66%)

-$39,318,000 (-77.78%)

BDSX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$3,440,000 (85.08%)

-$23,062,000 (-552.57%)

-$3,534,000 (-38.75%)

-$2,547,000 (12.98%)

Net Cash Flow from Financing

$52,050,000 (78.69%)

$29,129,000 (-50.53%)

$58,882,000 (4565.77%)

$1,262,000 (-98.44%)

Net Cash Flow from Operations

-$48,649,000 (-112.72%)

-$22,870,000 (49.15%)

-$44,972,000 (-59.35%)

-$28,223,000 (-32.09%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$39,000 (99.77%)

-$16,803,000 (-261.94%)

$10,376,000 (135.16%)

-$29,508,000 (-151.92%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$3,440,000 (85.08%)

-$23,062,000 (-552.57%)

-$3,534,000 (-38.75%)

-$2,547,000 (-17.00%)

Issuance (Repayment) of Debt Securities

-$95,000 (-101.04%)

$9,118,000 (-28.62%)

$12,773,000 (182.33%)

-$15,514,000 (-196.72%)

Issuance (Purchase) of Equity Shares

$56,275,000 (94.99%)

$28,860,000 (-52.03%)

$60,162,000 (244.97%)

$17,440,000 (-76.22%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$6,638,000 (23.54%)

$5,373,000 (-9.86%)

$5,961,000 (20.57%)

$4,944,000 (33.30%)

Depreciation Amortization & Accretion

$5,773,000 (4.83%)

$5,507,000 (-5.77%)

$5,844,000 (83.89%)

$3,178,000 (9.47%)

BDSX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

78.20% (6.39%)

73.50% (16.67%)

63.00% (43.18%)

44.00% (-14.89%)

Profit Margin

-60.20% (43.31%)

-106.20% (38.00%)

-171.30% (-116.29%)

-79.20% (-15.12%)

EBITDA Margin

-40.50% (46.43%)

-75.60% (43.96%)

-134.90% (-107.22%)

-65.10% (-42.14%)

Return on Average Equity (ROAE)

-216.00% (99.28%)

-30185.80% (-3722.92%)

-789.60% (-348.13%)

-176.20% (-616.72%)

Return on Average Assets (ROAA)

-42.60% (29.70%)

-60.60% (32.21%)

-89.40% (-98.67%)

-45.00% (-19.36%)

Return on Sales (ROS)

-48.60% (44.01%)

-86.80% (42.17%)

-150.10% (-111.71%)

-70.90% (-36.08%)

Return on Invested Capital (ROIC)

-36.90% (48.03%)

-71.00% (80.84%)

-370.50% (-137.50%)

-156.00% (-61.83%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-4.64 (-61.25%)

-2.88 (-93.73%)

-1.48 (55.68%)

-3.35 (-7.62%)

Price to Sales Ratio (P/S)

2.78 (-9.62%)

3.08 (21.47%)

2.53 (-4.59%)

2.66 (24.05%)

Price to Book Ratio (P/B)

10.66 (-70.67%)

36.35 (673.71%)

4.7 (-35.16%)

7.25 (-44.25%)

Debt to Equity Ratio (D/E)

3.66 (-82.27%)

20.64 (488.12%)

3.51 (22.78%)

2.86 (47.24%)

Earnings Per Share (EPS)

-0.33 (48.44%)

-0.64 (58.71%)

-1.55 (1.90%)

-1.58 (75.62%)

Sales Per Share (SPS)

0.55 (-8.03%)

0.6 (-34.14%)

0.91 (-54.42%)

1.99 (-78.84%)

Free Cash Flow Per Share (FCFPS)

-0.4 (28.09%)

-0.56 (51.48%)

-1.15 (-2.49%)

-1.12 (76.90%)

Book Value Per Share (BVPS)

0.16 (187.50%)

0.06 (-88.55%)

0.49 (-32.18%)

0.72 (-91.53%)

Tangible Assets Book Value Per Share (TABVPS)

0.59 (-36.46%)

0.93 (-42.67%)

1.62 (-10.51%)

1.81 (-90.58%)

Enterprise Value Over EBIT (EV/EBIT)

-7 (-40.00%)

-5 (-150.00%)

-2 (33.33%)

-3 (88.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-8.76 (-64.62%)

-5.32 (-160.78%)

-2.04 (42.11%)

-3.52 (87.40%)

Asset Turnover

0.71 (24.21%)

0.57 (9.20%)

0.52 (-8.26%)

0.57 (3.64%)

Current Ratio

2.76 (132.15%)

1.19 (-49.12%)

2.33 (55.05%)

1.51 (-43.83%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$52,089,000 (-13.40%)

-$45,932,000 (5.31%)

-$48,506,000 (-57.64%)

-$30,770,000 (-30.70%)

Enterprise Value (EV)

$253,114,961 (28.23%)

$197,384,383 (87.73%)

$105,145,082 (-15.90%)

$125,020,847 (-78.55%)

Earnings Before Tax (EBT)

-$42,931,000 (17.67%)

-$52,146,000 (20.32%)

-$65,447,000 (-51.64%)

-$43,159,000 (-37.67%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$28,900,000 (22.11%)

-$37,103,000 (28.00%)

-$51,531,000 (-45.27%)

-$35,473,000 (-70.19%)

Invested Capital

$97,753,000 (26.71%)

$77,145,000 (126.89%)

$34,001,000 (1637.81%)

-$2,211,000 (-108.41%)

Working Capital

$25,167,000 (301.58%)

$6,267,000 (-79.45%)

$30,495,000 (108.11%)

$14,653,000 (-72.87%)

Tangible Asset Value

$76,339,000 (0.24%)

$76,154,000 (11.86%)

$68,078,000 (37.67%)

$49,449,000 (-46.70%)

Market Capitalization

$222,564,961 (33.69%)

$166,476,383 (71.95%)

$96,815,082 (-32.27%)

$142,938,847 (-73.29%)

Average Equity

$19,872,750 (11403.76%)

$172,750 (-97.92%)

$8,288,750 (-66.16%)

$24,491,250 (126.62%)

Average Assets

$100,757,250 (17.06%)

$86,074,500 (17.51%)

$73,246,000 (-23.58%)

$95,846,000 (15.41%)

Invested Capital Average

$93,907,750 (56.42%)

$60,034,250 (287.71%)

$15,484,500 (-37.49%)

$24,771,750 (0.52%)

Shares

145,467,295 (60.78%)

90,476,295 (114.94%)

42,093,514 (55.78%)

27,020,576 (1.81%)